Portage Biotech Inc.

NASDAQ: PRTG · Real-Time Price · USD
8.55
-0.25 (-2.84%)
At close: Aug 15, 2025, 3:59 PM
8.57
0.23%
After-hours: Aug 15, 2025, 07:52 PM EDT

Portage Biotech Cash Flow Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Net Income
-75.34M -104.67M -19.17M -17.19M
Depreciation & Amortization
54K 1K n/a 1.02M
Stock-Based Compensation
2.64K 4.28M 9.14M 8.83M
Other Working Capital
982K 21K -983K -633K
Other Non-Cash Items
70.57M 106.21M -670K 1.36M
Deferred Income Tax
-10.56M -17.88M 4.39M 2.45M
Change in Working Capital
982K -10K -461K -744K
Operating Cash Flow
-14.3M -12.07M -6.76M -4.28M
Capital Expenditures
n/a -3K n/a 1M
Cash Acquisitions
n/a n/a n/a -1M
Purchase of Investments
n/a n/a n/a -1M
Sales Maturities Of Investments
2.81M n/a n/a 140K
Other Investing Acitivies
n/a -614K n/a -860
Investing Cash Flow
2.81M -617K n/a -860K
Debt Repayment
-40K -2M n/a -970K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-20K -1.1M -1.75M -1.25M
Financial Cash Flow
5.97M -117K 27.35M 4.76M
Net Cash Flow
-5.52M -12.81M 20.58M -382K
Free Cash Flow
-14.3M -12.08M -6.76M -3.28M